Calendar Clinuvel Pharmaceuticals Limited

Equities

CUV

AU000000CUV3

Market Closed - Australian S.E. 01:10:10 2024-03-28 am EDT 5-day change 1st Jan Change
14.36 AUD +1.27% Intraday chart for Clinuvel Pharmaceuticals Limited +1.48% -10.25%

Chart calendar Clinuvel Pharmaceuticals Limited

6.YHYiAdtuUu6diSaC1ZkbTk3JyVvoFRYya6PaBcYl7lc.UVsbVpo6E6L7vkLB5dV0CX6RhSKPQ3hgWvmVdL96vjMzH0FLsAxrpOz-VQ~3711407c5dd41db3d14fcc450bb54c35

Upcoming events on Clinuvel Pharmaceuticals Limited

2024-08-27 Q4 2024 Earnings Release (Projected)
2025-02-24 Q2 2025 Earnings Release (Projected)
2025-08-26 Q4 2025 Earnings Release (Projected)
2026-02-23 Q2 2026 Earnings Release (Projected)

Past events on Clinuvel Pharmaceuticals Limited

2024-02-22 02:00 am Q2 2024 Earnings Call
2024-02-21 05:48 pm Q2 2024 Earnings Release
2023-11-20 Roadshow
2023-11-19 Roadshow
2023-11-14 Bell Potter Healthcare Conference
2023-10-30 07:00 pm Annual General Meeting
2023-10-17 J P Morgan Bio Tech Conference
2023-09-04 Ex-dividend day for final dividend
2023-09-03 Roadshow
2023-08-30 Roadshow
2023-08-29 Roadshow - Wilsons Advisory
2023-08-29 04:00 am Q4 2023 Earnings Call
2023-08-28 08:36 pm Q4 2023 Earnings Release
2023-02-22 05:41 pm Interim 2023 Earnings Release
2023-01-30 05:32 pm December 2022 Sales and Revenue Release - Activities Report
2022-11-14 Jefferies London Healthcare Conference
2022-10-30 September 2022 Sales and Revenue Release
2022-10-25 07:00 pm Annual General Meeting
2022-09-11 H.C. Wainwright Global Investment Conference
2022-09-05 Ex-dividend day for final dividend

Past dividends on Clinuvel Pharmaceuticals Limited

2023-09-04 Annual 0.05 AUD
2022-09-05 Annual 0.04 AUD
2021-09-01 Annual 0.025 AUD
2020-09-02 Annual 0.025 AUD
2019-09-03 Annual 0.025 AUD
2018-09-20 Final Payment 0.02 AUD

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023 2024
Net sales
Million AUD
Released
Forecast
Spread
31,0
31,0
0.15%
32,6
34,0
-4.22%
48,0
42,1
14%
65,7
67,4
-2.5%
78,3
80,3
-2.41%

89,5

EBITDA
Million AUD
Released
Forecast
Spread
17,6
16,5
6.92%
13,0
12,2
6.78%
26,1
21,0
24.07%
37,4
30,1
24.37%
37,2
39,7
-6.37%

43,9

EBIT
Million AUD
Released
Forecast
Spread
17,6
16,4
7.01%
12,6
11,9
5.88%
25,2
20,7
22.12%
36,7
29,2
25.5%
36,4
38,9
-6.31%

42,9

Earnings before Tax (EBT)
Million AUD
Released
Forecast
Spread
18,1
16,9
7.19%
13,1
12,7
3.43%
25,7
23,8
8.04%
34,3
29,5
16.34%
45,6
42,6
7.12%

50,6

Net income
Million AUD
Released
Forecast
Spread
18,1
16,9
7.3%
16,6
12,7
31.08%
24,7
19,5
26.98%
20,9
20,3
2.82%
30,6
29,8
2.59%

34,6

EPS
AUD
Released
Forecast
Spread
0,37
0,35
4.57%
0,33
0,26
26.92%
0,48
0,39
25.42%
0,40
0,40
-0.19%
0,59
0,59
1.02%

0,68

Announcement Date28/08/1926/08/2026/08/2130/08/2229/08/23-

Quarterly results

Fiscal PeriodJune 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales
Million AUD
Released
Forecast
Spread
13,6
20,3
-32.84%
34,3
28,1
22.22%



41,1
35,6
15.42%



49,0
46,3
5.76%
32,3
34,4
-6.32%

53,9

EBITDA
Million AUD
Released
Forecast
Spread
5,61
10,5
-46.54%
20,5
20,2
1.41%
9,85
10,0
-1.53%
27,7
20,8
33.24%
14,9
19,2
-22.36%
22,3
24,6
-9.36%
13,7
15,2
-9.62%

33,3

EBIT
Million AUD
Released
Forecast
Spread
5,61
10,3
-45.5%
19,6
19,7
-0.38%
9,45
9,70
-2.53%
27,3
20,0
36.75%
14,5
18,9
-23.12%
21,9
24,1
-9.19%
13,2
15,5
-15.08%

33,3

Earnings before Tax (EBT)
Million AUD
Released
Forecast
Spread
5,81
11,0
-47.17%
19,9
20,7
-3.86%
8,73
10,0
-12.74%
25,6
20,1
27.34%
14,6
19,1
-23.56%
31,0
25,5
21.49%
14,8
17,7
-16.35%

37,3

Net income
Million AUD
Released
Forecast
Spread
6,49
11,0
-41.02%
18,2
12,1
50.75%
5,87
11,5
-48.95%
15,0
13,4
12%
11,4
16,1
-29.27%
19,2
19,1
0.61%
10,9
14,8
-26.11%

24,9

EPS
AUD
Released
Forecast
Spread
0,13
0,22
-41.47%
0,36
0,24
49.37%
0,11
0,23
-49.33%
0,29
0,26
9.89%
0,22
0,31
-29.49%
0,37
0,37
0.82%
0,21
0,28
-22.91%

0,49

Announcement Date23/02/2126/08/2122/02/2230/08/2223/02/2329/08/2321/02/24-

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise